Jason Resendez Profile picture
Jun 1, 2021 21 tweets 17 min read Read on X
The brilliant @KBibbinsDomingo opens today's @theNASEM workshop by reminding us that #EquityInClinicalTrials is about justice, better science, and economic opportunity. There are NO excuses to prop up the status quo, y'all. #BrainHealthEquity
#AdaoraAdimora points out that the research enterprise too often focuses on enrolling individuals that are easy to enroll.
Yes, ma'am...an example of how privilege is exalted by the current system. 🧵/2 #EquityInClinicalTrials
Dr. #AdaoraAdimora underscores the importance of hiring diverse staff that understand, empathize, and reflect the communities to advance #EquityInClinicalTrials. It's past time for research to be anchored by **communities** and not institutions. 🧵/3
Now Dr. #MahasinMujahid underscores 1) the need for geographic diversity in research to contextualize our insights 2) examine who we are funding to do this work (are they from the community?) & 3) consider the #SDOH & structural racism in our science #EquityInClinicalTrials 🧵/4
"Time is a social determinant of health" Dr. #MahasinMujahid makes a brilliant point on the need to rethink how we compensate participants.
Too often our approach / policies overvalue data collection while undervaluing the time of participants #EquityInClinicalTrials 🧵/5
Yes! #AdaoraAdimora raises a critical point: fair compensation of research participants shouldn't be considered coercion "that's patronizing... we wouldn't think twice about compensating physicians for their time." 🧵/6 #EquityInClinicalTrials
"A lack of fair compensation can lead to mistrust" #AdaoraAdimora Excellent point. This entire dialogue around adequate compensation for participant time is so critical & ripe for policy change, y'all. #EquityInClinicalTrials 🧵/7
.@gradydoctor does a powerful job of anchoring the "Beyond Mistrust" panel in the everyday injustices that BIPOC communities face...police brutality, racial profiling, etc. We must look beyond #Tuskegee #EquityInClinicalResearch 🧵/8
Now @gradydoctor is bringing in the lived-experiences and words of the community into this #EquityInClinicalTrials dialogue. #WhatsYourWhy? We need the research enterprise to reflect on this question more across the study design process. 🧵/9
Loving these @AAMCtoday principles of trustworthiness presented by @PM_Alberti "You are not the only experts" Yes! Lived-experience must be better valued across the research design process. #EquityInClinicalTrials 🧵/10
Challenge assumptions to do better in your work: "not all gay people go to the club, not all Black people go to church" @PM_Alberti #EquityInClinicalTrials 🧵/11
Now @GinaGreenHarris highlights how the @WisconsinADRC has structured its staffing to achieve its goal of building #BrainHealthEquity! "Building a framework to support the community is our goal, research is not our first priority." #EquityInClinicalTrials 🧵/12
"What we like to talk about is liberation." @WisconsinADRC #EquityInClinicalTrials 🧵/13
Empowerment is key to the work of the @WisconsinADRC & @GinaGreenHarris. Leveraging an asset based model helps center PEOPLE in research. #EquityInClinicalTrials 🧵/14
"We didn't mention research until 3 years into our work" @GinaGreenHarris highlights the long game that the @WisconsinADRC is taking to do better / more equitable #Alzheimers science #EquityInClinicalTrials 🧵/15
And for all y'all haters out there, @GinaGreenHarris has brought receipts on the effectiveness of the @WisconsinADRC's asset based model for sustainable engagement / recruitment #EquityInClinicalTrials 🧵/16
Now @BiotechSusan kicks off a panel w/ @sinsipuede @rgreersmith #SarahKrug on the importance of patient-centered engagement in research, building on today's themes of valuing PEOPLE across the enterprise. #EquityInClinicalTrials 🧵/17
.@sinsipuede highlights a great new resource from the @NPWF on "Choosing Health Equity:
Understanding Decision Points in Research" to help improve diversity in healthoutcomes research nationalpartnership.org/our-work/resou… #EquityInClinicalTrials 🧵/18
.@sinsipuede of the @NPWF gets to the point: "This is an issue of power" highlighting the larger dynamics at play that prioritize institutions over communities #EquityInClinicalTrials 🧵/19
"It's important to keep in mind what community infrastructure is compared to academic and industry research" @sinsipuede Yes! Sinsi & @rgreersmith remind us that the power dynamic is uneven between stakeholders #EquityInClinicalTrials 🧵/20
And that's a wrap on the second @theNASEM workshop on #EquityInClinicalTrials - critical conversations that will inform action oriented recommendations. Thanks to all those folks that stayed with us!
My key takeaway message from today 👇

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Jason Resendez

Jason Resendez Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(